About Cape Fear Arthritis Care
Clinical Trials at Cape Fear Arthritis Care
During the past decade, Cape Fear Arthritis Care conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cape Fear Arthritis Care" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "R-Pharm International, LLC" with 3 trials
sponsored, "Gilead Sciences" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Radius Health, Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cape Fear Arthritis Care"
#1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Cape Fear Arthritis Care
According to Clinical.Site data, the most researched conditions in "Cape Fear Arthritis Care" are
"Rheumatoid Arthritis" (7 trials), "Arthritis" (1 trials), "Autoimmune Diseases" (1 trials), "Chronic Gout" (1 trials) and "Connective Tissue Diseases" (1 trials). Many other conditions were trialed in "Cape Fear Arthritis Care" in a lesser frequency.
Clinical Trials Intervention Types at Cape Fear Arthritis Care
Most popular intervention types in "Cape Fear Arthritis Care" are "Drug" (9 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "TNF Inhibitor" (2 trials), "Adalimumab 40mg q2w" (1 trials) and "Concomitant treatment" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cape Fear Arthritis Care
The vast majority of trials in "Cape Fear Arthritis Care" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Cape Fear Arthritis Care
Currently, there are NaN active trials in "Cape Fear Arthritis Care".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Cape Fear Arthritis Care,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cape Fear Arthritis Care, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".